Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
Cancer Management and Research|November 11, 2020
Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid AdenocarcinomaWei Li, Qian Li, Yiyi Yu, et al.Journal of Experimental & Clinical Cancer Research : CR|January 8, 2022
Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancerMengxuan Zhu, Pengfei Zhang, Shan Yu, et al.Journal of Surgical Oncology|March 27, 2021
Reevaluation of lymphovascular invasion in gastric cancer using endothelial markers D2-40 and EVG: Enhanced detection, better predictor of lymph node metastasis and biological aggressivenessJingdong Liu, Haojie Li, Peng Zhou, et al.Biochimie|April 3, 2023
Cancer stem cell-derived exosome-induced metastatic cancer: An orchestra within the tumor microenvironmentKhalid Rashid, Aqeel Ahmad, Semmal Syed Meerasa, et al.Medical Oncology (Northwood, London, England)|August 14, 2015
Low-dosed docetaxel showed equivalent efficacy but improved tolerability compared with oxaliplatin in the S-1-based first-line chemotherapy regimen for metastatic or recurrent gastric adenocarcinomaMengzhou Guo, Yiyi Yu, Yan Wang, et al.Oncotargets and Therapy|November 10, 2018
Platelet-to-lymphocyte ratio and lymphocyte-to-white blood cell ratio predict the efficacy of neoadjuvant chemotherapy and the prognosis of locally advanced gastric cancer patients treated with the oxaliplatin and capecitabine regimenCheng Tang, Xi Cheng, Shan Yu, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 6, 2016
Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing ChemotherapyZhiming Wang, Li Liang, Yiyi Yu, et al.Translational Gastroenterology and Hepatology|May 8, 2025
The effective molecular characteristics of PD-1 inhibitor combination regimen as the first-line treatment for Chinese patients with HER2-positive gastric cancer: a real-world retrospective analysis studyLingyun Zhang, Bin Guan, Wei Li, et al.BMC Gastroenterology|June 14, 2022
Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world studyLingyun Zhang, Jiayu Zhang, Yan Wang, et al.Oncotargets and Therapy|February 23, 2017
Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathwayYuehong Cui, Qian Li, Hong Li, et al.Pageof 6